Canadian Psychiatric Association
 

Editorial Credits/ Crédits éditorials

Subscription Rates /Prix d'abonnements

Advertising Rates / Tarifs publicitaires (PDF)


Guest Editorial
Psychiatry, Technology, and the Corn Fields of Iowa

Harry Karlinsky

(PDF)


In Review
The Internet’s Impact on the Practice of Psychiatry

Rima Styra

(PDF)

Clinical and Educational Telepsychiatry Applications: A Review
Donald M Hilty, Shayna L Marks, Doug Urness, Peter M Yellowlees, Thomas S Nesbitt

(PDF)

Portable Computing in Psychiatry
John Luo

(PDF)


Original Research
Assessing and Monitoring Antipsychotic-Induced Movement Disorders in Hospitalized Patients: A Cautionary Study

Leonardo Cortese, Mandar Jog, T Jeffrey McAuley, V Kotteda, Giuseppe Costa

(PDF)

Sociodemographic Factors Associated With Comorbid Major Depressive Episodes and Alcohol Dependence in the General Population
JianLi Wang, Nady El-Guebaly

(PDF)

Delineating the Population Served by a Mobile Crisis Team: Organizing Diversity
Janet Landeen, Julie Pawlick, Steven Rolfe, Ian Cottee, Melanie Holmes

(PDF)

Detecting Women at Risk for Postnatal Depression Using the Edinburgh Postnatal Depression Scale at 2 to 3 Days Postpartum
Frédérique Teissèdre, Henri Chabrol

(PDF)


Review Paper
Ethics in Psychiatric Research: Study Design Issues

Gordon DuVal

(PDF)


Brief Communication
The Prevalence of Psychological Morbidity in West Bank Palestinian Children

Tanya L Zakrison, Amira Shahen, Shaban Mortaja, Paul A Hamel

(PDF)


Book Reviews
(PDF)

Beyond Technique in Solution Focused Therapy.
Reviewed by
Llewellyn W Joseph, MD, FRCPC


The Epidemiology of Schizophrenia.
Reviewed by
Mary V Seeman, MD


The Private Self.
Reviewed by
Paul Ian Steinberg, MD, FRCPC


Treatment Planning in Psychotherapy: Taking the Guesswork Out of Clinical Care.
Reviewed by
Gilbert Pinard, MD, FRCPC


Pharmacogenetics of Psychotropic Drugs.
Reviewed by
Gustavo Turecki MD PhD


Psychotherapy and Counselling in Practice. A Narrative Framework.
Reviewed by
Paul KB Dagg


Oedipus and Beyond: A Clinical Theory.
Reviewed by
Paul Ian Steinberg, MD, FRCPC


Letters to the Editor
(PDF)

Modafinil Treatment of Excessive Sedation Associated With Divalproex Sodium

Ziprasidone in Parkinson’s Disease Psychosis

Combined Oral Venlafaxine and Intravenous Clomipramine-A: Successful Temporary Response in a Patient With Extremely Refractory Depression

Doxepin Increases Serum Cholesterol Levels

Re: Suicide: The Persisting Challenge

Reply: Suicide: The Persisting Challenge

Depression and a History of Alcoholism

Gains in Speeded Information Processing Following Clozapine Treatment of Schizophrenia

Problems With Crystallizing Phenomenology and Nosology in Adolescent Psychiatry

Serotonin Syndrome With Prolonged Dysphagia

Letters to the Editor

Re: Suicide: The Persisting Challenge

The recent editorial by Dr Isaac Sakinofsky (1) and the other articles appearing in the June 2003 issue of the Journal discuss a most important aspect of psychiatric practice. People at risk for suicide are vulnerable to various situations, some of which have been identified and accepted. For example, the replacement of coal gas, with its heavy concentration of carbon monoxide, by natural gas resulted in a marked drop in suicides. The use of electroconvulsive therapy (ECT) also contributed positively to preventing suicides. Unfortunately, all innovations—such as the replacement of imipramine by the monoamine oxidase inhibitors and later the selective serotonin reuptake inhibitors—have been followed by an upsurge of suicides. I recall that, when I cautiously introduced imipramine, I was impressed by the markedly reduced number of patients requiring ECT. We had a fairly large Department of Psychological Medicine in the Teaching Hospital in Birmingham, UK, and because of a bed shortage, we developed comprehensive outpatient services and a day hospital as early as 1950. In the first year of using imipramine, we reduced the numbers requiring ECT by 50%, and in the following year, by another 50%. Thus, within 2 years, only 25% of all patients with severe depression had to have a full course of ECT. As the years passed, the number grew smaller; with the advent of lithium, we lowered them further.

We did not send these “suicidals” to the several mental hospitals in the West Midlands of England. In fact, patients with severe depression were soon much less likely to be admitted to the mental hospitals in the region (2). In my 25 years in the unit, not one of my patients committed suicide, and I have since maintained this “score.” Management is a major factor in the treatment of patients with severe depression. If the family is involved, the risk explained, and their active cooperation secured, we should be able to get the patient over the major hurdle in a week or so. Preventing suicide is a major responsibility that psychiatrists have to face. It is about the only way to lose a patient. As already noted, it requires much attention to management; in this regard, psychiatrists have to resist the interference of the team, because a team can greatly disturb the management of actively suicidal patients. I used to say that 10 people who do not know are no better than 1 person who does not know.

I abolished the practice of issuing suicide caution cards to the nursing staff. I entered the following statement in the case notes: “In my opinion, this patient can be treated in the general ward of a general hospital.” The nursing staff were most grateful, for they were no longer overwhelmed with suicide caution cards that could not guarantee more supervision. In fact, this practice led to less supervision. It meant that the psychiatrist constantly reviewed the situation and immediately introduced appropriate treatment. The patient and relatives were grateful for speedy recoveries. After she had seen me writing this opinion on the chart, I recall the ward sister saying, “But Dr Sim, you are accepting the full responsibility.” I replied that that was why they paid me more. It is much easier to follow this course, for no time was wasted in debating policy with the team, whose only advantage is to ensure that nobody is to blame.

In Canada, young men with ready access to firearms are another source of suicide vicims. The numbers are staggering, and I used them to illustrate a point when I was asked to present a paper at the 10th International Congress for Suicide Prevention and Crime Intervention (3). In 1 year, there were 150 homicides, while 1500 men under age 31 years committed suicide with firearms. They were mainly young men working on farms who had access to firearms while suffering from severe depression that was not recognized. I also suggested that the Canadian Rifle Association should be actively engaged in preventing this horrible loss and that affected young men be persuaded to hand over their weapons until they have been successfully treated. Again, a major aspect in this treatment is the capacity to manage the situation, and I am concerned that this aspect of psychiatric treatment receives little emphasis in psychiatrist training. There would be convulsions in parliament if 1500 troops were wiped out owing to poor management, but this horrible loss from suicide, which is preventable, is allowed to continue. Cosy indolence is a poor substitute for preventive measures.

Finally, drug houses should not be allowed to replace a drug that effectively treats severe depression with “pep pills” that have the capacity to release aggressive tendencies. There is much more to say—but not in a letter to the editor.

References

1. Sakinofsky I. Suicide: the persisting challenge. Can J Psychiatry 2003;48;289–91.

2. Orwin A, Sim M. The mental hospital: effects of an alternative psychiatric service. Lancet 1965;i:644.

3. Sim M. Gun control and suicide. Proceedings of the 10th International Congress for Suicide Prevention and Crime Intervention. Ottawa (ON): International Association for Suicide Prevention; 1979. p 187–9.

Dr Myre Sim MD, FRCP, FRCPsych, FRCPC FAPA
Victoria, British Columbia




CJP Archives in English | Archives RCP en français
Supplements and Position Paper Inserts |
Lignes directrices cliniques, énoncés de principe et communiqués
Author Index to 2002 | Index RCP des auteurs 2002
Subject Index to 2002 | Index RCP des sujets 2002
Information for Contributors | Information à l'intention des auteurs
Style Notes for Contributors
Subscription Rates | Prix d'abonnements
Advertising Rates | Tarifs publicitaires
CPA Home | Page d'accueil